UK markets closed
NIKKEI 225
26,402.84 -508.36 (-1.89%) HANG SENG
20,120.68 -523.62 (-2.54%) CRUDE OIL
110.79 +1.20 (+1.09%) GOLD FUTURES
1,839.80 +23.90 (+1.32%) DOW
31,261.67 -228.40 (-0.73%) BTC-GBP
24,090.61 +657.15 (+2.80%)
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
At close: 04:45PM BST
| Previous close | 1,756.20 |
| Open | 1,749.20 |
| Bid | 1,725.40 x 0 |
| Ask | 1,725.40 x 0 |
| Day's range | 1,712.00 - 1,756.80 |
| 52-week range | 1,215.83 - 1,817.00 |
| Volume | |
| Avg. volume | 10,749,254 |
| Market cap | 88.034B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 17.16 |
| EPS (TTM) | 100.90 |
| Earnings date | 27 Jul 2022 |
| Forward dividend & yield | 0.75 (4.24%) |
| Ex-dividend date | 19 May 2022 |
| 1y target est | 1,798.36 |
- Zacks
4 Large Drug Stocks to Watch as the Industry Recovers
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.
- Zacks
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies
AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.
- Zacks
Gilead (GILD) HIV Studies Removed From FDA's Clinical Hold
Gilead (GILD) studies evaluating injectable lenacapavir for HIV treatment and HIV pre-exposure prophylaxis (PrEP) removed from hold.
© 2022 Yahoo. All rights reserved.
